Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Rudolf Schneider has worked on the following 13 EPO patent applications which have been published in the last five years:

EP11305731

Methods and uses based on Slfn2 expression and relating to the identification and profiling of compounds for use in the treatment or prevention of pain

IPC classification:
C12Q 1/68, G01N 33/50
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP11708487

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/68
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Kathrin Körner, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Agent:
Kathrin Körner, 2SPL Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP11306400

Gene cluster for biosynthesis of griselimycin and methylgriselimycin

IPC classification:
C07K 14/36, C12R 1/465
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP12306043

Combination treatments involving antibodies to human PCSK9

IPC classification:
A61K 39/395, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP12306068

Combination treatments involving antibodies to human PCSK9

IPC classification:
A61K 39/395, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11305088

Human antibodies to PSCK9 for use in methods of treatment based on particular dosage regimens (11565)

IPC classification:
A61K 31/00, A61K 39/395
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11721769

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Sanofi, S.A.
Agent:
Kathrin Körner, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Agent:
Kathrin Körner, 2SPL Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP11708485

METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND INVOLVED IN PAIN AS WELL AS METHODS OF DIAGNOSING ALGESIA

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/68
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Kathrin Körner, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Agent:
Kathrin Körner, 2SPL Patentanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP12306039

Human antibodies to PCSK9 for use in methods of treating particular groups of subjects

IPC classification:
A61K 39/395, C07K 5/02, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11305939

Pharmaceutical composition for treating a metabolic syndrome

IPC classification:
A61K 31/155, A61K 38/18, A61K 38/26, A61P 3/10
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11306712

Method for recombinant production of labyrinthopeptins and functional derivatives thereof

IPC classification:
A61K 38/16, C07K 14/36, C12N 15/76
Applicant:
Sanofi, S.A.
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11721069

METHODS OF DIAGNOSING ALGESIA

IPC classification:
C12Q 1/68
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Rudolf Schneider, Sanofi-Aventis Deutschland GmbH
Status:
PATENT GRANTED
EP11709920

Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/68
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Kathrin Körner, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Agent:
Kathrin Körner, 2SPL Patentanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature